Actym Therapeutics, pioneering a new drug modality to treat solid tumors, has appointed Thomas Smart as Chief Executive Officer.   With over two decades of experience in senior management and executive roles as well as Board of Directors positions across the biopharmaceutical industry, Smart brings a track record in leading organizations through value-building transitions. His breadth of expertise will be highly beneficial to Actym as it prepares to enter clinical evaluation of its lead candid...